Top

Published in:

01-02-2019 | Original Contributions

Longitudinal Comparison of the Effect of Gastric Bypass to Sleeve Gastrectomy on Liver Function in a Bariatric Cohort: Tehran Obesity Treatment Study (TOTS)

Authors: Mohammad Ali Kalantar Motamedi, Alireza Khalaj, Maryam Mahdavi, Majid Valizadeh, Farhad Hosseinpanah, Maryam Barzin

Published in: Obesity Surgery | Issue 2/2019

Abstract

Background

Patients with morbid obesity commonly have fatty liver disease and elevated liver enzymes. While surgery effectively induces weight loss, bariatric techniques may differ regarding liver function improvement.

Objectives

To evaluate and compare the trends of liver function recovery after gastric bypass surgery (GB) with sleeve gastrectomy (SG).

Setting

University hospitals, Iran.

Methods

Adult bariatric candidates without a history of alcohol consumption or other etiologies of liver disease who underwent SG (n = 682) or GB (n = 355) were included. Trends of weight loss parameters and alanine transaminase (ALT), aspartate transaminase (AST), and alkaline phosphatase (ALP) at 0, 6 (in 90.4%), 12 (in 83.5%), and 24 months (in 67.1%) were compared using generalized estimating equations method.

Results

Overall, 1037 patients with mean age of 38.4 ± 11.2 and mean body mass index of 44.9 ± 6.2 kg/m² were analyzed. Seventy-eight percent of patients had fatty liver by ultrasound. Both GB and SG patients lost significant weight, with GB patients having a higher percentage of excess weight loss at 24 months (80.1% vs. 75.9%, P_{between-group} = .008). SG patients showed more favorable trends in liver chemistries with significantly lower ALT at 12 months and AST and ALP levels at 6 and 12 months. However, the two groups were comparable at 24 months. Significantly more GB patients developed high ALT at 6 and high AST at 6 and 12 months. Undergoing GB was associated with smaller 0–12-month changes in ALT, AST, and ALP.

Conclusions

Bariatric surgery resulted in improvement in liver function parameters, with SG showing advantages over GB in the first postoperative year.

Younossi ZM, Stepanova M, Afendy M, et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol. 2011;9(6):524–30. https://doi.org/10.1016/j.cgh.2011.03.020.CrossRefPubMed

Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328–57. https://doi.org/10.1002/hep.29367.CrossRefPubMed

Leite NC, Salles GF, Araujo ALE, et al. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus. Liver Int. 2009;29(1):113–9. https://doi.org/10.1111/j.1478-3231.2008.01718.x.CrossRefPubMed

Targher G, Bertolini L, Padovani R, et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care. 2007;30(5):1212–8. https://doi.org/10.2337/dc06-2247.CrossRefPubMed

Balupuri S, Cheung AC, Mahawar KK, et al. Non-alcoholic fatty liver disease (NAFLD) and bariatric surgery. In: Agrawal S, editor. Obesity, bariatric and metabolic surgery: a practical guide. Cham: Springer International Publishing; 2016. p. 629–36.CrossRef

Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34(3):274–85. https://doi.org/10.1111/j.1365-2036.2011.04724.x.CrossRefPubMed

Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116(6):1413–9.CrossRefPubMed

Kwo PY, Cohen SM, Lim JK. ACG clinical guideline: evaluation of abnormal liver chemistries. Am J Gastroenterol. 2017;112(1):18–35. https://doi.org/10.1038/ajg.2016.517.CrossRefPubMed

Burza MA, Romeo S, Kotronen A, et al. Long-term effect of bariatric surgery on liver enzymes in the Swedish Obese Subjects (SOS) study. PLoS One. 2013;8(3):e60495. https://doi.org/10.1371/journal.pone.0060495.CrossRefPubMedPubMedCentral

10.

Ooi GJ, Burton PR, Doyle L, et al. Effects of bariatric surgery on liver function tests in patients with nonalcoholic fatty liver disease. Obes Surg. 2017;27(6):1533–42. https://doi.org/10.1007/s11695-016-2482-8.CrossRefPubMed

11.

Bower G, Toma T, Harling L, et al. Bariatric surgery and non-alcoholic fatty liver disease: a systematic review of liver biochemistry and histology. Obes Surg. 2015;25(12):2280–9. https://doi.org/10.1007/s11695-015-1691-x.CrossRefPubMed

12.

Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2013. Obes Surg. 2015;25(10):1822–32. https://doi.org/10.1007/s11695-015-1657-z.CrossRefPubMed

13.

Barzin M, Motamedi MAK, Serahati S, et al. Comparison of the effect of gastric bypass and sleeve gastrectomy on metabolic syndrome and its components in a cohort: Tehran Obesity Treatment Study (TOTS). Obes Surg. 2017;27(7):1697–704. https://doi.org/10.1007/s11695-016-2526-0.CrossRefPubMed

14.

Mahawar KK, Kumar P, Parmar C, et al. Small bowel limb lengths and Roux-en-Y gastric bypass: a systematic review. Obes Surg. 2016;26(3):660–71. https://doi.org/10.1007/s11695-016-2050-2.CrossRefPubMed

15.

Mahawar KK. Another fatal outcome with a biliopancreatic limb length of 200 cm with one anastomosis gastric bypass. Obes Surg. 2017;27(7):1882–3. https://doi.org/10.1007/s11695-017-2695-5.CrossRefPubMed

16.

Barzin M, Hosseinpanah F, Motamedi MA, et al. Bariatric surgery for morbid obesity: Tehran Obesity Treatment Study (TOTS) rationale and study design. JMIR Res Protoc. 2016;5(1):e8. https://doi.org/10.2196/resprot.5214.CrossRefPubMedPubMedCentral

17.

Peterli R, Wolnerhanssen BK, Vetter D, et al. Laparoscopic sleeve gastrectomy versus Roux-Y-gastric bypass for morbid obesity-3-year outcomes of the prospective randomized Swiss Multicenter Bypass Or Sleeve Study (SM-BOSS). Ann Surg. 2017;265(3):466–73. https://doi.org/10.1097/sla.0000000000001929.CrossRefPubMed

18.

Aller R, Pacheco D, Izaola O, et al. Effect on liver enzymes of biliopancreatic diversion: 4 years of follow-up. Ann Nutr Metab. 2015;66(2–3):132–6. https://doi.org/10.1159/000375506.CrossRefPubMed

19.

Alizai PH, Wendl J, Roeth AA, et al. Functional liver recovery after bariatric surgery--a prospective cohort study with the LiMAx test. Obes Surg. 2015;25(11):2047–53. https://doi.org/10.1007/s11695-015-1664-0.CrossRefPubMed

20.

Motamedi MAK, Barzin M, Ebrahimi M, et al. Severe fatal protein malnutrition and liver failure in a morbidly obese patient after mini-gastric bypass surgery: case report. Int J Surg Case Rep. 2017;33(71–4. https://doi.org/10.1016/j.ijscr.2017.02.033.CrossRef

21.

Motamedi MAK, Rakhshani N, Khalaj A, et al. Biopsy-proven progressive fatty liver disease nine months post mini-gastric bypass surgery: a case study. Int J Surg Case Rep. 2017;39(168–71. https://doi.org/10.1016/j.ijscr.2017.07.062.CrossRef

22.

Tsai JH, Ferrell LD, Tan V, et al. Aggressive non-alcoholic steatohepatitis following rapid weight loss and/or malnutrition. Mod Pathol. 2017;30(6):834–42. https://doi.org/10.1038/modpathol.2017.13.CrossRefPubMedPubMedCentral

23.

Caiazzo R, Lassailly G, Leteurtre E, et al. Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study. Ann Surg. 2014;260(5):893–8; discussion 98–9. https://doi.org/10.1097/sla.0000000000000945.CrossRefPubMed

24.

Kruschitz R, Luger M, Kienbacher C, et al. The effect of Roux-en-Y vs. omega-loop gastric bypass on liver, metabolic parameters, and weight loss. Obes Surg. 2016;26(9):2204–12. https://doi.org/10.1007/s11695-016-2083-6.CrossRefPubMedPubMedCentral

25.

Billeter AT, Senft J, Gotthardt D, et al. Combined non-alcoholic fatty liver disease and type 2 diabetes mellitus: sleeve gastrectomy or gastric bypass?-a controlled matched pair study of 34 patients. Obes Surg. 2016;26(8):1867–74. https://doi.org/10.1007/s11695-015-2006-y.CrossRefPubMed

26.

van Zutphen T, Ciapaite J, Bloks VW, et al. Malnutrition-associated liver steatosis and ATP depletion is caused by peroxisomal and mitochondrial dysfunction. J Hepatol. 2016;65(6):1198–208. https://doi.org/10.1016/j.jhep.2016.05.046.CrossRefPubMed

27.

Csak T, Ganz M, Pespisa J, et al. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology. 2011;54(1):133–44. https://doi.org/10.1002/hep.24341.CrossRefPubMed

28.

Verna EC, Berk PD. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery. Semin Liver Dis. 2008;28(4):407–26. https://doi.org/10.1055/s-0028-1091985.CrossRefPubMed

29.

Lupoli R, Milone M, Di Minno A, et al. Haemostatic and fibrinolytic changes in obese subjects undergoing bariatric surgery: the effect of different surgical procedures. Blood Transfus. 2015;13(3):442–7. https://doi.org/10.2450/2014.0183-14.CrossRefPubMedPubMedCentral

30.

Kalinowski P, Paluszkiewicz R, Ziarkiewicz-Wroblewska B, et al. Liver function in patients with nonalcoholic fatty liver disease randomized to Roux-en-Y gastric bypass versus sleeve gastrectomy: a secondary analysis of a randomized clinical trial. Ann Surg. 2017;266(5):738–45. https://doi.org/10.1097/SLA.0000000000002397.CrossRefPubMed

Title: Longitudinal Comparison of the Effect of Gastric Bypass to Sleeve Gastrectomy on Liver Function in a Bariatric Cohort: Tehran Obesity Treatment Study (TOTS)
Authors: Mohammad Ali Kalantar Motamedi
Alireza Khalaj
Maryam Mahdavi
Majid Valizadeh
Farhad Hosseinpanah
Maryam Barzin
Publication date: 01-02-2019
Publisher: Springer US
Published in: Obesity Surgery / Issue 2/2019
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-018-3537-9

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Longitudinal Comparison of the Effect of Gastric Bypass to Sleeve Gastrectomy on Liver Function in a Bariatric Cohort: Tehran Obesity Treatment Study (TOTS)

Abstract

Background

Objectives

Setting

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Objectives

Setting

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2019

Tailored One Anastomosis Gastric Bypass: 3-Year Outcomes of 94 Patients

Laparoscopic Roux-En-Y Gastric Bypass Versus Sleeve Gastrectomy on Pelvic Floor Disorders in Morbidly Obese Women: a Prospective Monocentric Pilot Study

Bariatric/Metabolic Surgery in the Asia-Pacific Region: APMBSS 2018 Survey

Maj. Gen. Prof Khalid Bin Ali Al Khalifa

Impact of Patient Attrition from Bariatric Surgery Practice on Clinical Outcomes

Psychological Support and Well-being in Post-Bariatric Surgery Patients